The total throughput of the plant is nominally 45 gh 1 of 6, which corresponds to 2. Nov 09, 2018 aliskiren is an antihypertensive blood pressure lowering medicine. The synthesis was accomplished in 12 steps starting from the known chloride 2. Aliskiren is an antihypertensive blood pressure lowering medication. Aliskiren is an antihypertensive blood pressure lowering medicine. Aliskiren, with its 40h halflife and ideal pharmacokinetics, can now address angiotensin production directly at its ratelimiting step.
Us patent for process for the preparation of aliskiren patent. Aliskiren is in a class of medications called direct renin inhibitors. In preclinical studies, pgp was found to be the major efflux system involved in intestinal absorption and elimination via biliary excretion of aliskiren. Clinical data have substantiated that the antihypertensive effectiveness of aliskiren is similar to that of the other major antihypertensive agents. Us20140256963a1 process for the preparation of aliskiren. Aliskiren tekturna for the treatment of hypertension. Daily administration of aliskiren hemifumarate and amlodipine besylate 300.
And then have the fivesteps method to produce the final product aliskiren, with the total yield of 15. This medicine is used to treat high blood pressure. Aliskiren, an octanamide, is the first of a new class of completely nonpeptide, low molecular weight, and orally active transitionstate renin inhibitors. The plant started with advanced intermediates, two synthetic steps away from the final active pharmaceutical ingredient, and ended with finished tablets. Tekturna aliskiren expanded indication and new formulation. Most other treatments on the formulary, including diuretics, betablockers, angiotensinconverting enzyme inhibitors, angiotensin ii receptor blockers, are either lower or similar in cost. Patents listed in the fda orange book drug database of aliskiren with information and expiryexpiration dates.
The present invention provides a novel process and novel intermediates useful in the synthesis of pharmaceutically active compounds, especially renin inhibitors, such as aliskiren, or a salt thereof, preferably aliskiren hemifumarate. Aliskiren tekturna aliskiren is a small molecule antihypertensive that was discovered as part of a study to develop inhibitors of the enzyme renin, a key regulator of blood pressure control a viable process synthesis was developed by speedelnovartis, which won approval for the drug from the fda in 2007 first in its class difficult. Tablets are imprinted with nvr on one side and il, iu, on the other side of the 150 mg and 300 mg tablets, respectively. Scheme 1, which is formulated as tablets containing 112 mg of the free base form of aliskiren 5. The pharmacokinetics of aliskiren remains unaffected by ethnicity, age, gender, hepatic impairment, renal impairment, and diabetes. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext.
Process for the preparation of aliskiren feb 15, 20 mylan laboratories limited the present invention relates to an improved process for the preparation of pure compound of formulaii, which is an intermediate in the preparation of aliskiren and further conversion of compound of formulaii into aliskiren or its pharmaceutically acceptable salts. The invention discloses a kind of preparation method of aliskiren, aliskiren is prepared using r tbutyl sulfonamide and compound viii, the chiral induction effect of r tbutyl sulfonamide is utilized to build second required chiral centre, and solve build below second, third, four chiral centres when need column chromatography for separation the problem of, so that the preparation method. Aliskiren may also be used for purposes not listed in this medication guide. It works by decreasing substances in the body that narrow blood vessels and raise blood pressure. Herein, the formal synthesis of aliskiren by iridium. Sica, in textbook of nephroendocrinology second edition, 2018. Tekturna aliskiren expanded indication and new formulation on november 14, 2017, noden pharma announced the fda approval of tekturna aliskiren, for the treatment of hypertension in adults and children 6 years of age and older, to lower blood pressure. The fda said that patients with diabetes who mix the drugs risk kidney damage, hypotension extremely low blood pressure. It works by decreasing certain natural chemicals that tighten the blood vessels, so blood vessels relax and the heart can pump blood more efficiently. Aliskiren brand names tekturna and rasilez is the first in a class of drugs called direct renin inhibitors. Mean auc and cmax of aliskiren are decreased by 71% and 85% when taken with a high fat meal. Aliskiren is 50% protein bound, and the apparent volume of distribution is 5 l.
A new synthesis of the orally active renin inhibitor aliskiren. Learn about drug interactions between aliskiren oral and losartan oral and use the rxlist drug interaction checker to check drug combinations. Aliskiren, a renin inhibitor drug, has received considerable attention, primarily because it is the first of the renin. In nine healthy volunteers aged 2034 years, after administration of oral. Read the patient information leaflet if available from your pharmacist before you start taking this medication and each time you. The throughput can be adjusted to values between 20 gh 1and 100 gh by changing control setpoints in. Aliskiren is the first in a new class of orally active, nonpeptide, low molecular weight renin inhibitors 5. Texas prior authorization program clinical criteria 150mg aliskirencontaining agents except valturna.
It is a transitionstate mimetic, with favorable physicochemical properties including high aqueous solubility 350 mgml at ph 7. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for tekturna aliskiren. The elimination t12 of aliskiren averaged 24 h 2045 h in healthy volunteers as well as in patients with dm. Aliskiren, enalapril, or aliskiren and enalapril in heart failure. Most other treatments on the formulary, including diuretics, betablockers, angiotensinconverting enzyme inhibitors, angiotensin ii receptor blockers, are either lower or. The efficient and selective formal total synthesis of aliskiren is described. Appending the end groups and functional group transformations completed the synthesis scheme 3. Aliskiren is the newest antihypertensive drug and the first orally active direct renin inhibitor to become available for clinical use. The warning also applies to patients who have renal impairment. Highlights of prescribing information these highlights do not include all the information needed to use tekturna safely and effectively. A novel synthesis of the renin inhibitor aliskiren based on an unprecedented disconnection between c5 and c6 was developed, in which the c5 carbon acts as a nucleophile and the amino group is introduced by a curtius rearrangement, which follows a simultaneous stereocontrolled generation of the c4 and c5 stereogenic centers by an asymmetric. It was expediently prepared by three different routes scheme 2. A total synthesis of aliskiren 20 was accomplished.
Aliskiren is a unique antihypertensive agent that acts by direct inhibition of renin and has only recently been introduced into clinical practice. Aliskiren is a reninangiotensinaldosterone system inhibitor that is used in patients with hypertension. While used for high blood pressure, other better studied medications are typically recommended due to concerns of. Aliskiren is a renin inhibitor used to treat high blood pressure hypertension by lowering blood pressure. Furthermore, aliskiren has a similar safety profile to placebo. Aliskiren is also metabolized by cytochrome p450 cyp 3a4 enzymes, but the exact extent of metabolism is unknown. A dosedependent rise in plasma renin concentration and suppression of plasma renin activity following aliskiren administration confirmed substantial renin inhibition 28,29.
Nov 28, 2017 tekturna tablets are supplied as a lightpink, biconvex round tablet containing 150 mg of aliskiren, and as a lightred biconvex ovaloid tablet containing 300 mg of aliskiren. See full prescribing information for complete boxed warning. Njegova trenutna licencirana indikacija je primarna hipertenzija. Tekturna aliskiren dosing, indications, interactions. Aliskiren information food and drug administration. Aliskiren has been linked to rare instances of serum aminotransferase elevations during therapy and rare cases of idiosyncratic, clinically apparent liver injury. The aliskiren trial of minimizing outcomes for patients with heart failure atmosphere included 7016 patients with heart failure and reduced left ventricular ejection fraction, of whom 2340 were randomly assigned to enalapril plus. Aliskirenmode of action and preclinical data springerlink. A convergent synthesis of the orally active renin inhibitor aliskiren 1 is described. And when comes to aliskiren synthesis, it could be done through the following way. Jul 08, 2015 aliskiren is a renin inhibitor used to treat high blood pressure hypertension by lowering blood pressure. The development and operation of the synthesis and workup steps of a fully integrated, continuous manufg. On april 19, the us food and drug administration issued a warning to diabetes patients not to combine the blood pressure medication aliskiren tekturna with ace inhibitors or angiotensin receptor blockers. We have designed a new strategy for the convergent synthesis of.
It was approved in 2007 for the treatment of hypertension. Feb 15, 20 process for the preparation of aliskiren feb 15, 20 mylan laboratories limited the present invention relates to an improved process for the preparation of pure compound of formulaii, which is an intermediate in the preparation of aliskiren and further conversion of compound of formulaii into aliskiren or its pharmaceutically acceptable salts. Direct renin inhibitor pregnancy risk category c first trimester, d second and third trimesters pregnancy risk category c first trimester, d second and third trimesters fda box warning drugs that act directly on the reninangiotensin system can cause injury and death to a developing fetus. Fda warns diabetes patients about combining aliskiren. Aliskiren is a direct renin inhibitor approved for the treatment of mild to moderate hypertension aliskiren has not been shown to improve cardiovascular outcomes. Aliskiren is used alone or in combination with some medications to treat high blood pressure. Aliskiren as addon therapy in the treatment of hypertensive. Dec 11, 2014 the altitude study aliskiren trial in type 2 diabetes using cardiovascular and renal disease endpoints was a 4year, multicentre, randomised, placebocontrolled trial that looked at type ii. We report a macrocycle route toward aliskiren, a drug presently marketed for the treatment of hypertension, using a highly stereocontrolled approach starting from a common isopropyl chiron. Aliskiren tekturna is the first direct renin inhibitor approved for the treatment of hypertension when used alone or in combination with other antihypertensive agents. Use the chemical resolution method to produce chiral fragment compound 1 and 2 which are needed in the synthesis of aliskiren. While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit. Pdf a new synthetic route towards aliskiren intermediates.
A novel transgenic rat model outfitted with the human renin and angiotensinogen genes allowed the testing of aliskiren in an animal model. Highlights of the synthesis include a challenging rcm reaction to produce a ninemembered unsaturated lactone, a highly stereoselective catalytic du bois aziridination, and a regio and. A key in our synthesis was to use the symmetric trans. Comparison of the blood pressure response with aliskiren was greater and of longer duration than with and acei or arbs. Aliskiren medicinal forms bnf content published by nice. Aliskiren is the firstinclass orally active direct renin inhibitor. Aliskiren definition of aliskiren by medical dictionary. Aliskiren side effects, dosage, interactions drugs. How to use aliskiren 300 mg tablet angiotensin inhibiting agents. Aliskiren is used to treat high blood pressure hypertension.
452 1150 554 855 677 1098 475 897 822 335 440 1399 464 1586 484 1059 347 157 1381 785 140 947 1481 1091 1500 494 576 1532 112 628 854 58 470 628 729 81 1459 179 1335 897 1130 1338 973 237 971 169